Clinical Trial Detail

NCT ID NCT02626338
Title Pilot Study of Crenolanib Combined With Cytarabine and Mitoxantrone in Subjects With R/R AML
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Arog Pharmaceuticals, Inc.
Indications

acute myeloid leukemia

Therapies

Crenolanib + Cytarabine + Mitoxantrone

Age Groups: adult

No variant requirements are available.